C3 complement polymorphism in patients suffering from obstructive chronic bronchopneumopathy in Tunisia;Polymorphisme du C3 du complément chez des patients atteints de bronchopneumopathie chronique obstructive en Tunisie

Annales de Biologie Clinique

Volumn 65, Issue 3, 2007, Pages 251-256

  Leban, N ^a   Haj Khelil, A ^a   Daimi, H ^a   Denden, S ^a   Slimene, F ^b   Mehdouani, K ^b   Abdennaji Guenounou, B ^c   Lefranc, G ^d   Perrin, P ^e   Ben Chibani, J ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b Hôpital Ibn Jazzar de Kairouan

^c Centre de Transfusion Sanguine de Gabes   (Tunisia)

^d UNIV MONTPELLIER   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

ARMS PCR; C3 gene; C3*S and C3*F polymorphism; Obstructive chronic bronchopneumonopathie (OCBP)

Indexed keywords

COMPLEMENT COMPONENT C3;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENETIC POLYMORPHISM; GENETICS; HUMAN; TUNISIA;

COMPLEMENT C3; HUMANS; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUNISIA;

EID: 34249881943     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2007.0054     Document Type: Article

References (23)

1. Mackay IR, Rosen FS. Complement, first of two parts. N Engl J Med 2001 ; 344 : 1058-66.
2. Welch TW, Blystone LW. C3 is central to the interstitial component of experimental immune complex glomerulonephritis. Clin Immunol 2005 ; 115 : 80-4.
3. Lusis AJ, Heinzmann C, Sparkes RS, et al. Regional mapping of human chromosome 19 : organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI. Proc Natl Acad Sci USA 1986 ; 83 : 3929-33.
4. Botto M, Fong KY, So AK, Koch C, Walport MJ. Molecular basis of human complement component C3. J Exp Med 1990 ; 172 : 1011-7.
5. Arvilomi H. Capacity of complement C3 phenotypes to bind on to mononuclear cells in man. J Exp Med 1974 ; 251 : 740.
6. Persson U, Truedsson L, Westman KWA, Segelmark M. C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculatis. Clin Exp Immunol 1999 ; 116 : 379-82.
7. Davrinche C, Rivat C. Polymorphism of the third component of human complement. Rev Fr Transfus Immunohematol 1982 ; 25 : 199-213.
8. Thuman JM, Holers VM. The central role of the alternative complement pathway in human disease. J Immunol 2006 ; 176 : 1305-10.
9. Weiss ST, DeMeo DL, Postma DS. COPD : problems in diagnosis and measurement. Eur Respir J 2003 ; 21 : 4s-12s.
10. Hoidal JR. Genetics of COPD : present and future. Eur Respir J 2001 ; 18 : 741-3.
11. Mal H, Crestani B, Aubier M, Fournier M. émphysème pulmonaire : évolution des concepts. Med Sci (Paris) 1999 ; 15 : 833-41.
12. 1-antitrypsin deficiency. Eur Respir J 2000 ; 15 : 886-90.
13. Barnes KC, Grant AV, Baltadzhieva D, et al. Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families. Genes Immun 2006 ; 7 : 27-35.
14. Hasegawa K, Tamari M, Shao C, et al. Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthama. Hum Genet 2004 ; 115 : 295-301.
15. Chibani J, Lefranc G, Constans J. Serum protein polymorphism among Tunisian Berbers : haptoglobins, transferrin and group specific component subtypes C3 and BF types. Ann Hum Biol 1985 ; 12 : 449-62.
16. Teisberg P. High voltage agarose electrophoresis in the study of C3 polymorphism. Vox Sang 1970 ; 19 : 47-56.
17. Tang S, Zhou W, Sheerin NS, Vaughan RW, Sacks SH. Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol 1999 ; 162 : 4336-41.
18. Ghanem N, Lefranc MP, Lefranc G. Polymorphism of the complement C3 gene in the Lebanese population. Exp Clin Immunogenet 1987 ; 4 : 222-6.
19. Luiselli D, Simoni L, Tarazona-Santos E, Pastor S, Pettener D. Genetic structure of Quechua-speakers of the central Andes and geographic patterns of gene frequencies in South Amerindian populations. Am J Phys Anthropol 2000 ; 113 : 5-17.
20. Akbari MT, Papiha SS, Roberts DF, Farhud DD. Genetic differentiation among Iranian Christian communities. Am J Hum Genet 1986 ; 38 : 84-98.
21. Messias-Reason IJ, Urbanetz L, Pereira da Cuncha C. Complement C3F and BFS allotypes are risk factors for Chagas disease cardiomyopathy. Tissue Antigens 2003 ; 62 : 308-12.
22. Csasza A, Duba J, Melegh B, et al. Increased frequency of the C3*F allele and the Leiden mutation of coagulation factor V in patients with severe coronary heart disease who survived myocardial infarction. Exp Clin Immunogenet 2001 ; 18 : 206-12.
23. Melnick SL, Go RCP, Cogen RB, Roseman JM. Allelic variants for complement factors C3, C4, and B in acute necrotizing ulcerative gingivitis. J Dent Res 1988 ; 67 : 851-4.